Viewing StudyNCT04485676



Ignite Creation Date: 2024-05-06 @ 2:58 PM
Last Modification Date: 2024-10-26 @ 1:41 PM
Study NCT ID: NCT04485676
Status: COMPLETED
Last Update Posted: 2022-07-22
First Post: 2020-06-16

Brief Title: Dalbavancin in Real Clinical Practice in Spain
Sponsor: Angelini Farmacéutica
Organization: Angelini Farmacéutica

Organization Data

Organization: Angelini Farmacéutica
Class: INDUSTRY
Study ID: ANG-DAL-2019-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Angelini Farmacéutica
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Effice Servicios Para la Investigacion SL INDUSTRY